Kambiz Yazdi
Stock Analyst at Jefferies
(1.95)
# 2,795
Out of 4,817 analysts
7
Total ratings
28.57%
Success rate
9.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $4.41 | +421.54% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $13.53 | +40.43% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $5.90 | +154.24% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.08 | +362.96% | 1 | Apr 12, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $75 → $128 | $35.34 | +262.20% | 2 | Mar 26, 2024 |
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $4.41
Upside: +421.54%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $13.53
Upside: +40.43%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $5.90
Upside: +154.24%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Praxis Precision Medicines
Mar 26, 2024
Maintains: Buy
Price Target: $75 → $128
Current: $35.34
Upside: +262.20%